Rasi Bhadramani AbbVie (NYSE:ABBV) and Xilio Therapeutics (NASDAQ:XLO) have entered into a collaboration and option-to-license
hapabapa AbbVie (NYSE:ABBV) said it has received FDA approval for its intravenous antibiotic treatment Emblaveo.
mi-viri Shares of Equillium (NASDAQ:EQ) soared 26% Thursday after the company and partner Biocon reported
iQoncept/iStock via Getty Images Healthcare has become the second-best performer in the S&P 500 (SP500)
Earnings Call Insights: AbbVie Inc. (NYSE:ABBV) Q4 2024 Management View CEO Rob Michael highlighted AbbVie’s
*Other Operating Data Consensus Source: Bloomberg More on AbbVie: AbbVie Non-GAAP EPS of $2.16 misses
AbbVie press release (NYSE:ABBV): Q4 Non-GAAP EPS of $2.16 misses by $0.10. Revenue of $15.1B
Dilok Klaisataporn/iStock via Getty Images Stock futures edged higher Friday morning as market participants weighed
Urupong AbbVie (NYSE:ABBV) is scheduled to announce Q4 earnings results on Friday, January 31st, before